Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Daniel O’Day, currently Chief Operating Officer (COO) of Roche Diagnostics has been appointed as COO of Roche Pharma effective September 1, 2012. He will succeed Pascal Soriot, who will leave Roche and take on new responsibilities outside the Group. Daniel O’Day will be succeeded by Roland […]
Farmingdale, NY — DNA measurements are very difficult to obtain. Besides needing special analysts who have been trained in DNA research, a laboratory needs the proper equipment to ensure they get the absolute best results possible. Not just any scientist is acceptable for the job and not just any machine is required for this highly […]
SAN DIEGO, — Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced that the latest release of the company’s enterprise electronic laboratory notebook (ELN), Symyx Notebook by Accelrys, offers a new multidimensional scientific spreadsheet for use in planning, executing and tracking a wide range of biological experiments. In addition, […]
WALTHAM, Mass. – PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has entered into a collaboration with Dr. John Iafrate and Dr. Long Le of the Massachusetts General Hospital (MGH) Pathology Department and Cancer Center to develop a sequencing informatics system for […]
ALBUQUERQUE, N.M.–Manhattan Scientifics (OTCBB: MHTX) announced today that its Senior Scientific subsidiary has named Steven C. Miller, Ph.D. to the position of Chief Commercialization Officer. Senior Scientific is developing and commercializing technology developed by Dr. Edward R. Flynn. Senior Scientifics’ nanotechnology and imaging technology can detect tumors and metastases much earlier than currently possible and […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2013 sales and earnings estimates. Based on the Company’s business planning and budgeting activities for the fiscal year ending September 30, 2013, management expects net sales to be in the range of $190 to $195 million and […]
ALAMEDA, Calif — BioTime, Inc. (NYSE MKT:BTX) announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStemR technology. Under the amended license, BioTime now is licensed worldwide for all […]
FRANKLIN LAKES, N.J., — BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies. Sirigen’s polymer technology is based on Nobel Prize-winning research in conductive plastics […]
PORT WASHINGTON, N.Y., – Pall Corporation (NYSE: PLL) announced today that H. Alex Kim has joined the company as Senior Vice President, Business Development and Strategic Planning. In this newly created position, Mr. Kim is responsible for leading the strategic planning process for Pall’s Industrial and Life Sciences business segments and driving both organic and […]
Microfluidics expert Dolomite is pleased to announce it is now a licensee of Japan Science and Technology Agency (“JST”) under JST’s microdroplet generation technology. Dolomite is authorised to grant sub-licences under JST’s microdroplet generation technologies. Dolomite offers a wide range of Droplet-forming devices featuring different junction geometries, channel sizes and surface properties. Droplet based microfluidics […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
